Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00303979 · ClinicalTrials.gov registry record

IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting

A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

Completed
Registry status
34,810
Enrollment target

NCT00303979 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 34,810 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00303979 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

COMPLETED
Registry status
34,810 participants
Enrollment target

Study Summary

The purpose of this study is to characterize current management of patients with either heart failure or prior myocardial infarction and left ventricular dysfunction and to assess the effect of education, specific clinical guidelines, reminder systems, comprehensive disease state management tools, benchmarked quality reports, and academic detailing on the use of evidence-based heart failure therapies in cardiology practices. This study is a quality improvement initiative that is being conducted through review of patient records.

Trial Details

FieldValue
Enrollment Target 34,810 participants
Start Date 2005-05
Est. Completion 2009-08

What the Registry Record Tells You About NCT00303979

The ClinicalTrials.gov registry entry for NCT00303979 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 34,810 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00303979 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00303979 about?

NCT00303979 is a clinical study titled "IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting". The purpose of this study is to characterize current management of patients with either heart failure or prior myocardial infarction and left ventricular dysfunction and to assess the effect of education, specific clinical guidelines, reminder systems, comprehensive disease state management tools, b...

What is the current status of trial NCT00303979?

This trial is currently completed. The enrollment target is 34,810 participants. The study started on 2005-05. Estimated completion is 2009-08.

Who is sponsoring clinical trial NCT00303979?

This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.